Align Technology, Inc.

Align Technology, Inc.(ALGN)股票分析

$149.340

+5.063 (+3.39%)收盘时

Loading chart…
最高
149.780
开盘
143.920
成交量加权均价
147.19
成交量
1.14M
市值
18.29B
最低
142.450
成交额
167.92M
企业价值/息税折旧摊销前利润(TTM)
9.75

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

AI 分析 of Align Technology, Inc. (ALGN)

持有

Align Technology Inc is currently a hold. The stock is trading at $142.71, which is significantly below the average analyst price target of $189, indicating potential upside. However, the stock has a relatively low RSI of 45.75, suggesting it may not be oversold, and recent downgrades from analysts reflect concerns about weakening demand and economic conditions. The forward P/E ratio of 11.67 is attractive compared to its historical performance, but the stock has dropped 8.54% year-to-date, indicating ongoing challenges. The main risk is the recent analyst downgrade citing a sharp deceleration in demand indicators, which could impact future earnings.

分析师评级(11)

上行空间 +33.05%
买入
11 买入
0 持有
0 卖出
当前: 149.34
最低
169.00
平均
198.70
最高
220.00

Stifel

2026-10-09

目标价

$175

买入

Evercore ISI

2026-10-05

目标价

$155

In Line

UBS

2026-07-23

目标价

$189

中性

BMO Capital

2026-07-08

目标价

$209

跑赢大盘

Leerink

2026-06-30

目标价

$230

跑赢大盘

估值指标

Align Technology, Inc.(ALGN)当前预期市盈率为 11.67,5 年平均预期市盈率为 27.32。

预期市盈率

低估
5 年均值 P/E
27.32
当前P/E
11.67
高估
41.20
低估
13.44

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
18.57
当前EV/EBITDA
9.75
高估
26.78
低估
10.37

预期市销率

低估
5 年均值 P/S
4.86
当前P/S
2.36
高估
7.17
低估
2.55

Alphio AI 对 ALGN 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ALGN

$210.76

情景价格

基

基准

基准 · 50%ALGN

$171.10

情景价格

悲

悲观

悲观 · 25%ALGN

$159.37

情景价格

持有 ALGN 的大户

C

Carmignac Gestion SA

+ 持有ALGN

+7.60%

3个月收益率

J

Jacobs Levy Equity Management Inc

+ 持有ALGN

+6.27%

3个月收益率

V

Veritas Investment Management LLP

+ 持有ALGN

+5.81%

3个月收益率

N

Ninety One UK Limited

+ 持有ALGN

+5.69%

3个月收益率

T

The Investment House LLC

+ 持有ALGN

+5.58%

3个月收益率

N

Nearwater Capital Markets, Limited

+ 持有ALGN

+4.86%

3个月收益率

事件时间线

2026-10-05 (ET)

09:00:00

Stock Futures Point to Modestly Lower Open as Investors Take a Breather

2026-08-12 (ET)

05:30:00

Align Wins Patent Infringement Case in China, Awarded RMB 10M

2026-07-29 (ET)

20:30:00

Major US Indices Close Lower, Semiconductor Stocks Plummet

17:00:00

Sees Q3 Adjusted Gross Margin Roughly 71%

17:00:00

Align Technology Increases 2026 Share Repurchase to $400M-$500M

资讯

ALGN 常见问题 —— 由 Alphio AI 解答

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Align Technology Inc is currently a hold. The stock is trading at $142.71, which is significantly below the average analyst price target of $189, indicating potential upside. However, the stock has a relatively low RSI of 45.75, suggesting it may not be oversold, and recent downgrades from analysts reflect concerns about weakening demand and economic conditions. The forward P/E ratio of 11.67 is attractive compared to its historical performance, but the stock has dropped 8.54% year-to-date, indicating ongoing challenges. The main risk is the recent analyst downgrade citing a sharp deceleration in demand indicators, which could impact future earnings.

11 analysts cover ALGN: 11 rate it Buy, 0 Hold and 0 Sell. The average price target is 198.70.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易